Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.215 23 days ( -14.75 % )
Last Price $54.69 -4.09 %
High/ Low $54.65 - $57.02 2.14%
Chg 7 Days -2.13 % $55.88 $54.69
Chg 30 Days 14.75 % $47.66 $54.69
Chg 12 mos 289.81 % $14.03 $54.69
Trend - 3 mos 34.67 % Width: 19.89 %
Trend - 12 mos 220.82 % Width: 59.10 %
Pred. range - 3 mos $70.38 - $84.38 28.69 % - 54.29 %
Pred. range - 12 mos $124.23 - $197.65 127.16 % - 261.40 %
Short MA avg 3 mos Buy 2024-03-26 - 3 days
Long MA avg 3 mos Sell 2024-02-23 - 25 days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2024-03-27 - 2 days
Long MA avg 12 mos Buy 2023-09-26 - 128 days
Short/Long MA avg 12 mos Buy 2023-10-09 - 119 days
Pivot Short Sell 2024-03-13 - 12 days
Bollinger Buy 2024-03-05 - 18 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT